Related references
Note: Only part of the references are listed.Influence of endogenous glucagon-like peptide-2 on lipid disorders in mice fed a high-fat diet
Sara Baldassano et al.
ENDOCRINE RESEARCH (2016)
Glucagon-like peptide-2 treatment improves glucose dysmetabolism in mice fed a high-fat diet
Sara Baldassano et al.
ENDOCRINE (2016)
Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer's Disease
Domenico Nuzzo et al.
CURRENT ALZHEIMER RESEARCH (2015)
GLP-2 as Beneficial Factor in the Glucose Homeostasis in Mice Fed a High Fat Diet
Sara Baldassano et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model
Ryo Sueyoshi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration
Noura El-Jamal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis
Xinfu Guan
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2014)
Physiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2
Daniel J. Drucker et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 76 (2014)
Feeding and Bone Turnover in Gastric Bypass
Juan P. Valderas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Incretin Receptor Null Mice Reveal Key Role of GLP-1 but Not GIP in Pancreatic Beta Cell Adaptation to Pregnancy
R. Charlotte Moffett et al.
PLOS ONE (2014)
GLP-2: What do we know? What are we going to discover?
Sara Baldassano et al.
REGULATORY PEPTIDES (2014)
Effects of high-fat diet and the anti-diabetic drug metformin on circulating GLP-1 and the relative number of intestinal L-cells
Camilla Kappe et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
Review article: a comparison of glucagon-like peptides 1 and 2
P. Janssen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Association of insulin resistance and GLP-2 secretion in obesity: a pilot study
Bruno Geloneze et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2013)
Central GLP-2 Enhances Hepatic Insulin Sensitivity via Activating PI3K Signaling in POMC Neurons
Xuemei Shi et al.
CELL METABOLISM (2013)
GLP-1 and GLP-2 as Yin and Yang of Intestinal Lipoprotein Production Evidence for Predominance of GLP-2-Stimulated Postprandial Lipemia in Normal and Insulin-Resistant States
Gustavo J. Hein et al.
DIABETES (2013)
Nutrient-Sensing Mechanisms in the Gut as Therapeutic Targets for Diabetes
Danna M. Breen et al.
DIABETES (2013)
Vertical Sleeve Gastrectomy Is Effective in Two Genetic Mouse Models of Glucagon-Like Peptide 1 Receptor Deficiency
Hilary E. Wilson-Perez et al.
DIABETES (2013)
GLP-1 Effects on Islets: Hormonal, Neuronal, or Paracrine?
Marc Y. Donath et al.
DIABETES CARE (2013)
Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance
Mohamed Asrih et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet
Sara Baldassano et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Alteration of the intestinal barrier and GLP2 secretion in Berberine-treated type 2 diabetic rats
C. Y. Shan et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Reprogramming of Intestinal Glucose Metabolism and Glycemic Control in Rats After Gastric Bypass
Nima Saeidi et al.
SCIENCE (2013)
Mechanisms of Obesity-Induced Inflammation and Insulin Resistance: Insights into the Emerging Role of Nutritional Strategies
Maeve A. McArdle et al.
Frontiers in Endocrinology (2013)
GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility
Xinfu Guan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity
Ricardo V. Cohen et al.
DIABETES CARE (2012)
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets
P. Marchetti et al.
DIABETOLOGIA (2012)
Food intake in lean and obese mice after peripheral administration of glucagon-like peptide 2
Sara Baldassano et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Metabolic surgery for type 2 diabetes
David E. Cummings
NATURE MEDICINE (2012)
Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes
Danna M. Breen et al.
NATURE MEDICINE (2012)
Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects
Lena M. S. Carlsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
Philip R. Schauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Geltrude Mingrone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart
T. Angelone et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2012)
GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier
G. W. Moran et al.
REGULATORY PEPTIDES (2012)
Review article: the role of gastric motility in the control of food intake
P. Janssen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes
Asger Lund et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Basal alpha-Cell Up-Regulation in Obese Insulin-Resistant Adolescents
Ram Weiss et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
GLP-2 receptor expression in excitatory and inhibitory enteric neurons and its role in mouse duodenum contractility
L. Cinci et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2011)
The Effect of PCSK1 Variants on Waist, Waist-Hip Ratio and Glucose Metabolism Is Modified by Sex and Glucose Tolerance Status
Anette P. Gjesing et al.
PLOS ONE (2011)
Gastric relaxation induced by glucagon-like peptide-2 in mice fed a high-fat diet or fasted
Alessandra Rotondo et al.
PEPTIDES (2011)
Glucagon-like peptide-1 relaxes gastric antrum through nitric oxide in mice
Alessandra Rotondo et al.
PEPTIDES (2011)
Role of cholinergic neurons in the motor effects of glucagon-like peptide-2 in mouse colon
Antonella Amato et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Gut Hypertrophy After Gastric Bypass Is Associated With Increased Glucagon-Like Peptide 2 and Intestinal Crypt Cell Proliferation
Carel W. le Roux et al.
ANNALS OF SURGERY (2010)
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus
K. Aaboe et al.
DIABETES OBESITY & METABOLISM (2010)
Glucagon-Like Peptide-2 Receptor Modulates Islet Adaptation to Metabolic Stress in the ob/ob Mouse
Jasmine Bahrami et al.
GASTROENTEROLOGY (2010)
Glucose-Dependent Insulinotropic Polypeptide Is Expressed in Pancreatic Islet α-Cells and Promotes Insulin Secretion
Yukihiro Fujita et al.
GASTROENTEROLOGY (2010)
A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet
Julio C. Fraulob et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2010)
GLP-2 Receptor Agonism Ameliorates Inflammation and Gastrointestinal Stasis in Murine Postoperative Ileus
Beverley A. Moore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model
Vincent E. de Meijer et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes
Mikkel Christensen et al.
REGULATORY PEPTIDES (2010)
Glucagon-like peptide-2 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro
Sara Baldassano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Glucagon-like peptide-2 relaxes mouse stomach through vasoactive intestinal peptide release
Antonella Amato et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Glucagon-Like Peptide-2 Reduces Intestinal Permeability But Does Not Modify the Onset of Type 1 Diabetes in the Nonobese Diabetic Mouse
Irene Hadjiyanni et al.
ENDOCRINOLOGY (2009)
Carcinogenic Effects of Exogenous and Endogenous Glucagon-Like Peptide-2 in Azoxymethane-Treated Mice
Roman Iakoubov et al.
ENDOCRINOLOGY (2009)
Glucagon-Like Peptide-2 Increases Intestinal Lipid Absorption and Chylomicron Production via CD36
Joanne Hsieh et al.
GASTROENTEROLOGY (2009)
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
P. D. Cani et al.
GUT (2009)
Glucagon-like peptide-2 increases mesenteric blood flow in humans
Lasse Bremholm et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats
David W. Nelson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Metabolic remodeling in adipocytes promotes ciliary neurotrophic factor-mediated fat loss in obesity
Seamus Crowe et al.
ENDOCRINOLOGY (2008)
Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats
Matthew C. Koopmann et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2008)
Interleukin-6 regulates pancreatic α-cell mass expansion
Helga Ellingsgaard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A switch from prohormone convertase (PC)-2 to PC1/3 expression in transplanted α-cells is accompanied by differential processing of proglucagon and improved glucose homeostasis in mice
Rhonda D. Wideman et al.
DIABETES (2007)
The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas
J. de Heer et al.
DIABETOLOGIA (2007)
Role of glial cell-line derived neurotropic factor family receptor α2 in the actions of the glucagon-like peptides on the murine intestine
Sean C. McDonagh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Metabolic endotoxemia initiates obesity and insulin resistance
Patrice D. Cani et al.
DIABETES (2007)
Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei
Niels Vrang et al.
BRAIN RESEARCH (2007)
Localization and activation of glucagon-like peptide-2 receptors on vagal afferents in the rat
David W. Nelson et al.
ENDOCRINOLOGY (2007)
Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus
F. K. Knop et al.
DIABETOLOGIA (2007)
Free fatty acids and insulin resistance
Jacques Delarue et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2007)
Increased intestinal permeability in obese mice:: new evidence in the pathogenesis of nonalcoholic steatohepatitis
Paola Brun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
Glucagon-like peptide 1 secretion by the L-cell - The view from within
Gareth E. Lim et al.
DIABETES (2006)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Glucagon-like peptide-2 protects against TPN-induced intestinal hexose malabsorption in enterally refed piglets
JJ Cottrell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Glucagon secretion in relation to insulin sensitivity in healthy subjects
B Ahren
DIABETOLOGIA (2006)
Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans
JJ Meier et al.
GASTROENTEROLOGY (2006)
GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow
XF Guan et al.
GASTROENTEROLOGY (2006)
Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice
ED Shin et al.
GASTROENTEROLOGY (2005)
GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors
C Orskov et al.
REGULATORY PEPTIDES (2005)
Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1
R Ugleholdt et al.
ENDOCRINOLOGY (2004)
Extrahypothalamic expression of the glucagon-like peptide-2 receptor is coupled to reduction of glutamate-induced cell death in cultured hippocampal cells
JA Lovshin et al.
ENDOCRINOLOGY (2004)
Effect of glucagon-like peptide-2 (GLP-2) on diurnal SGLT1 expression
AP Ramsanahie et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Increased glucose uptake promotes oxidative stress and PKC-δ activation in adipocytes of obese, insulin-resistant mice
I Talior et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
No effect of physiological concentrations of glucagon-like peptide-2 on appetite and energy intake in normal weight subjects
LB Sorensen et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2
A Au et al.
BIOCHEMICAL JOURNAL (2002)
The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist
J Thulesen et al.
REGULATORY PEPTIDES (2002)
Modulation of specific intestinal epithelial progenitors by enteric neurons
M Bjerknes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling
J Lovshin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Potential targets for glucagon-like peptide 2 (GLP-2) in the rat:: distribution and binding of i.v. injected 125I-GLP-2
J Thulesen et al.
PEPTIDES (2000)
In vivo and in vitro degradation of glucagon-like peptide-2 in humans
B Hartmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake
M Tang-Christensen et al.
NATURE MEDICINE (2000)
Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse
MA Benjamin et al.
GUT (2000)
Enteroendocrine localization of GLP-2 receptor expression in humans and rodents
B Yusta et al.
GASTROENTEROLOGY (2000)
Share Paper
